![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1273578
¼¼°èÀÇ Á¢¼±À¯µ¿¿©°ú ½ÃÀå ¿¹Ãø(-2028³â)Tangential Flow Filtration Market Forecasts to 2028 - Global Analysis By Product, Membrane Material (Nylon and Polyvinylidene Difluoride and Other Materials), Technique, Application, End User and By Geography |
Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ Á¢¼±À¯µ¿¿©°ú(Tangential Flow Filtration) ½ÃÀåÀº 2022³â 15¾ï ´Þ·¯¸¦ Â÷ÁöÇß½À´Ï´Ù.2028³â 35¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 15.2%ÀÇ CAGR ±Ô¸ð·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.
Á¢¼±À¯µ¿¿©°ú(TFF)´Â »ýüºÐÀÚ Á¤Á¦ ¹× ºÐ¸®¸¦ À§ÇÑ È¿°úÀûÀÎ Á¢±Ù¹ýÀÔ´Ï´Ù. Á¢¼± À¯µ¿ ¿©°ú´Â ±³Â÷ À¯µ¿ ¿©°ú·Îµµ ¾Ë·ÁÁ® ÀÖÀ¸¸ç ¼¼Æ÷ äÃë »ó·ù °øÁ¤°ú ¹ÙÀÌ¿À Á¦Á¶¿¡ »ç¿ëµÇ´Â ÇÏ·ù °øÁ¤ ¸ðµÎ À¯¿ëÇÕ´Ï´Ù. 10 ml ¼öõ ¸®ÅÍ »ùÇà ¿ë¾×À» ³óÃàÇϰí Å»¿°½Ãų ¼ö ÀÖ½À´Ï´Ù. ¼öÈ®ÇÑ ¼¼Æ÷ Çöʾ×, ¹Ì¼¼ÇÑ »ýüºÐÀÚ, ¹ßÈ¿ ºê·Î¾², ¼¼Æ÷¿ëÇØ¾× µîÀ» ´ë·®À¸·Î ºÐȹÇÔÀ¸·Î½á ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.
¹Ì±¹¿¡ º»»ç¸¦ µÐ µ¶¸³ÀûÀÎ ÇмúÀû ºñ¿µ¸® ¿¬±¸ ¼¾ÅÍÀÎ Tufts Center for the Study of Drug Development 2021³â º¸°í¼¿¡ µû¸£¸é, »óÀåÇϰí ÀÖ´Â ÃÖ´ë ¹ÙÀÌ¿À ±â¼ú ±â¾÷ ¼¼°èÀÇ ¿¬±¸ °³¹ßºñ´Â 2001³â 48¾ï ´Þ·¯¿¡ À̸¦ Àü¸ÁÀ̸ç, 2020³â 550¾ï ´Þ·¯ ±Ô¸ð¿¡ ´ÞÇÏ¿© ¸Å³â 13.7%°¡ Áõ°¡ÇÒ Àü¸ÁÀÔ´Ï´Ù.
´ëÇ¥ÀûÀÎ Á¢¼±À¯µ¿¿©°ú °øÁ¤Àº ¿ª»ïÅõ¸·°ú ³ª³ë¿©°ú¸¦ Æ÷ÇÔÇÕ´Ï´Ù. ³óÃà ¹× Åõ¼® ¿©°ú ±â¼úÀº Á¢¼± À¯µ¿ ¿©°ú¸¦ »ç¿ëÇÕ´Ï´Ù. ¿ëÁú ºÐÀÚ¸¦ À¯ÁöÇÑ Ã¤·Î ¾×ü¸¦ Á¦°ÅÇÔÀ¸·Î½á ¿ë¾× ³óµµ¸¦ ³ôÀÔ´Ï´Ù. Åõ¼® ¿©°ú´Â ÀÛÀº ÀÔÀÚ¿Í °Å´ëÇÑ ÀÔÀÚ°¡ ºÐ¸®µÇ°í ³ª¸ÓÁö ¿°À»º° ¿ÏÃæ¾×À¸·Î ¾Ä¾î ³»¸é ¸¶Áö¸·À¸·Î ÃÑ ³óµµ¸¦ º¯°æÇÏÁö ¾Ê°í ÀÛÀº ÀÔÀÚ¸¦ ³²±é´Ï´Ù. ÀÌ ¹æ¹ýÀº ³²Àº ¿°À» ¹°·Î ¾Ä¾î¼ ¿ë¾× ³óµµ¸¦ ³·Ãß´Â µ¥¿¡µµ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ¿Í °°ÀÌ, Á¢¼±À¯µ¿¿©°ú ÀÌ¿ëÀÌ Áõ°¡Çϰí ÀÖ´Â °ÍÀÌ ¿¹Ãø ±â°£ Áß Á¢¼±À¯µ¿¿©°ú ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.
Á¦Á¶ ¼³ºñ °Ç¼³°ú ½Å¼³¿¡´Â ¸¹Àº ¼³ºñ ÅõÀÚ°¡ ÇÊ¿äÇϸç, ¼Ò±Ô¸ð »ç¾÷ÀÚ´Â ¿É¼ÇÀ¸·Î ´ëÀÀÇϱ⠾î·Á¿ï ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¿ø½ÉºÐ¸®, ´ÙÀÌ·ºÆ® ÇÃ·Î¿ì ¿©°ú, ÇÁ¸®ÄÚÆ® ¿©°ú µî ÷´Ü ±â¼ú Á¸Àç´Â ¼¼°èÀÇ Á¢¼±À¯µ¿¿©°ú ½ÃÀå È®´ë¸¦ ¹æÇØÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ¸¹Àº Á¦¾à ȸ»ç´Â ÇØ¿Ü ±â¼ú, °æÇè ¹× ´É·ÂÀ» È¿°úÀûÀ¸·Î Ȱ¿ëÇϱâ À§ÇØ Ç×»ó Á¦Á¶ ¾Æ¿ô¼Ò½ÌÀ» ¼öÇàÇÕ´Ï´Ù. ±× °á°ú ¿ÏÁ¦Ç° °¡°ÝÀÌ »ó½ÂÇÏ°í ½ÃÀå È®´ë°¡ ÀúÇØµÉ ¼ö ÀÖ½À´Ï´Ù.
Á¢¼±À¯µ¿¿©°ú(TFF)´Â »ýüºÐÀÚ ºÐ¸®, Á¤Á¦¿¡ ÁïÈ¿¼ºÀÌ ÀÖ´Â È¿°úÀûÀÎ ±â¼úÀÔ´Ï´Ù. ¸é¿ªÇÐ, ´Ü¹éÁúÈÇÐ, ºÐÀÚ»ý¹°ÇÐ(DNA/RNA/¿Ã¸®°í´ºÅ¬·¹¿ÀƼµå), »ýÈÇÐ, ¹Ì»ý¹°ÇÐ µî ¸¹Àº °úÇÐ ¿µ¿ª¿¡¼ À¯¿ëÇÕ´Ï´Ù. TFF´Â ¼ö³â°£ ´Ü¹éÁú°ú ÆéƼµå ³óÃà, Å»¿°, ¼¼Æ÷ ¹è¾ç¾×À¸·ÎºÎÅÍ Ç×ü³ª ÀçÁ¶ÇÕ ´Ü¹éÁú ȸ¼ö, Á¤Á¦, Èñ¹ÚÇÑ ´Ü¹éÁú È¥ÇÕ¹° ºÐȹ¿¡ »ç¿ëµÇ¾î ¿Ô½À´Ï´Ù. ¶Ç, Ä¡·á¹ýÀÌ ÁýÁßÄ¡·á·Î ÀÌÇàÇÏ´Â °¡¿îµ¥, À¯ÀüÀÚ ÀçÁ¶ÇÕ ´Ü¹éÁú Ä¡·á¿¡ ÀÀ¿ëÀº Å« È®»êÀ» º¸À̰í ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿ÀÀǾàǰ¾÷°è´Â ÀçÁ¶ÇÕ ´Ü¹éÁúÀ» »óǰÈÇÏ´Â °æÇâÀÌ ÀÖÀ¸¸ç, Á¢¼±À¯µ¿¿©°ú ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
ÀǾàǰ »ç¾÷ Á¤ºÎ ¾ö°ÝÇÑ ¹ý±Ô º¸±ÞÀº ¼¼°èÀÇ Á¢¼±À¯µ¿¿©°ú ½ÃÀå¿¡ µµÀüÀ» Á¦°øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °Ô´Ù°¡ ½ÃÀå¿¡´Â ÀüÅëÀûÀÎ À¯Åë °æÀï»ç°¡ Á¸ÀçÇϱ⠶§¹®¿¡ ½Å±Ô ÁøÀÔ ±â¾÷ÀÌ Á¦Ç° ¿ÀÆÛ³ª ½Å±Ô ±â¼úÀ» È«º¸Çϱ⠾î·Á¿öÁö°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ½ÃÀå Áß¿ä °æÀï»ç´Â ´Ù¾çÇÑ Á¾·ù ¿©°ú Á¦Ç°À» Á¦°øÇÏ°í °í°´À¸·ÎºÎÅÍ ³ôÀº ¼öÁØ ºê·£µå ·Î¿Æ¼¸¦ ¾ò°í Àֱ⠶§¹®¿¡ ½Å±Ô ÁøÀÔ ±â¾÷ÀÌ ÀÌ ¾÷°è ¹ßÆÇÀ» ±¸ÃàÇÏ´Â °ÍÀº ´õ¿í ¾î·Á¿öÁö°í ÀÖ½À´Ï´Ù.
COVID-19 ÆÇµ¥¹ÍÀº ¼¼°èÀÇ °æÁ¦Àû, »çȸÀû ºñ¿ëÀ» Áõ°¡½Ã۰í, °¢±¹ Á¤ºÎ´Â ¹é½Å °³¹ß ¹× Á¦Á¶ °È¸¦ Ã˱¸Çß½À´Ï´Ù. Á¢¼±À¯µ¿¿©°ú Á¦Ç°Àº COVID-19 ¿¬±¸¿¡ Á¡Á¡ ´õ ¸¹ÀÌ »ç¿ëµË´Ï´Ù. ¹é½Å °³¹ßÀ» À§ÇÑ ¿©°ú ¹× Á¤Á¦¿Í °°Àº ´Ù¿î½ºÆ®¸² °øÁ¤À» Áö¿øÇϱâ À§ÇØ ´Ù¾çÇÑ ¿©°ú ±â¼ú ¹× Àç·á°¡ »ç¿ëµË´Ï´Ù. ¶ÇÇÑ ÀϺΠ¹ÙÀÌ¿À ÀǾàǰ ȸ»ç´Â ¹é½Å °³¹ßÀ» °³¼±Çϰí À¯ÇàÀ» ºÀ¼âÇϱâ À§ÇØ ¸î °¡Áö Àü·«À» µµÀÔÇß½À´Ï´Ù. COVID-19 À¯ÇàÀº ÇÊÅÍ Á¦Á¶»ç°¡ Á¦Á¶ ¼³ºñ¸¦ È®ÀåÇÒ ¼ö ÀÖ´Â ±âȸµµ ³º°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÇÊÅÍ Á¦Ç°Àº ¹é½Å ¹× ±âŸ ÀǾàǰ Á¦Á¶¿¡ »ç¿ëµÇ±â ¶§¹®¿¡ ¹é½Å ´ë·® »ý»êÀº Á¢¼± À¯µ¿ ¿©°ú Á¦Ç° ¼ö¿ä¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌĨ´Ï´Ù.
¸âºê·¹ÀÎ ÇÊÅÍ´Â Á¦¾à »ê¾÷À» Áß½ÉÀ¸·Î ¸¹Àº »ê¾÷ ÇÊÅÍ ½Ã½ºÅÛÀÌ »ç¿ëµÇ±â ¶§¹®¿¡ À¯¸®ÇÑ ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ÀÌ ºÐ¾ß È®´ë´Â PCTE, PVDF, PTFE, PES µî ´Ù¾çÇÑ Á¾·ù ÇÊÅÍ¿¡ ½±°Ô Á¢±ÙÇÒ ¼ö Àֱ⠶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ °ü·Ã °øÁ¤ ´Ù¾çÇÑ ¸· ¿©°ú ¸éÀû°ú ±â°ø Å©±â¸¦ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â Á¡µµ ÀÌ ºÐ¾ß È®´ë¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.
¼¼Æ÷ ºÐ¸® ½Ã Á¤¹Ð ¿©°ú ±â¼ú ÀÌ¿ëÀÌ Áõ°¡Çϰí Àֱ⠶§¹®¿¡, Á¤¹Ð ¿©°ú ºÐ¾ß´Â ¿¹Ãø ±â°£ Áß¿¡ °¡Àå ºü¸¥ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ÇÑÆí, Á¤¹Ð ¿©°ú¸·Àº ¹Ì»ý¹° Á¦°Å, ´Ü¹éÁú ºÐ¸®, ¸·Ã³¸® µî ´Ù¾çÇÑ °úÁ¦¿¡ ´ëÀÀÇϱâ À§ÇØ »ç¿ëµÇ¸ç, ÀÌ ºÎ¹® È®´ë¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¶Ç, ±¸¸Û Á÷°æÀÌ 0.1-10m·Î ´Ù¾çÇϱ⠶§¹®¿¡, ÆÄ¿ï¸µÀǾïÁ¦³ª ºÎÀ¯ ÀÔÀÚ ºÐȹÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀÎÀº °°Àº ºÐ¾ß ¼ºÀå¿¡ ±â¿©ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
¾Æ½Ã¾ÆÅÂÆò¾ç Áö¿ªÀº »ý¹° Á¦Á¦ ¹× ÀǾàǰ ¼ö¿ä°¡ Áõ°¡ÇÏ°í ±¹³»¿Ü ±â¾÷ ´Ù¾× ÅõÀÚ, Áß±¹, ÀϺ», Çѱ¹ µî ½ÅÈï ½ÃÀå CMO È®´ë°¡ ¾÷°è ¼ºÀåÀ» µÞ¹ÞħÇϰí Àֱ⠶§¹®¿¡ ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °Ô´Ù°¡, Ä¡·á Çö´ëÈ, °Ç° °ü¸® ÀÎÇÁ¶ó °³Ã´, Àúºñ¿ë ÀǾàǰ ¿ä±¸ ÁÖ¸ñÀº APAC TFF ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ´Â °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
ºÏ¹Ì´Â °¡Àå ³ôÀº ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ´Â ¹ÙÀÌ¿ÀÄ¡·á ¼ö¿ä¸¦ ÃæÁ·½Ã۱â À§ÇÑ ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º Ȱµ¿ Áõ°¡,¸¸¼º Áúȯ ¹× À¯ÀüÀÚ ÀÌ»ó ºóµµ Áõ°¡, Ä¡·á ¾ÈÀü¼º Áö½Ä È®´ë, ÇコÄɾî ȯ°æ °È°¡ ÀÌ Áö¿ª ¼ºÀåÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù ¶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ Áö¿ø Á¤ºÎ Á¸Àçµµ °³¹ßÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
2021³â 12¿ù, Donaldson Company(¹Ì±¹)´Â »ý¸í°øÇÐ ¹× ±âŸ »ý¸í°úÇÐ ½ÃÀå »ç¿ëµÇ´Â Á¢¼±À¯µ¿¿©°ú ½Ã½ºÅÛ°ú °°Àº ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º Àåºñ¸¦ ¼³°è ¹× Á¦Á¶ÇÏ´Â Solaris»ç(ÀÌÅ»¸®¾Æ)¸¦ ÀμöÇß½À´Ï´Ù. ÀÌ Àμö´Â Á¦¾à ¾÷°è ȸ»ç Æ÷Æ®Æú¸®¿À¸¦ È®´ëÇÕ´Ï´Ù.
2020³â 3¿ù, ´Ù³ªÇÏ´Â Á¦³Ê·² ÀÏ·ºÆ®¸¯ ÄÄÆÛ´Ï·ÎºÎÅÍ ¹ÙÀÌ¿ÀÆÄ¸¶ »ç¾÷À» ÀμöÇß½À´Ï´Ù. ÀÌ ºÎ¼´Â Cytiva¶ó°í ºÒ¸®¿ì¸ç Danaher life Sciences ºÎ¹® ¾Æ·¡ ¿î¿µµÇ´Â µ¶¸³ ȸ»ç°¡ µÉ ¿¹Á¤ÀÔ´Ï´Ù.
According to Stratistics MRC, the Global Tangential Flow Filtration Market is accounted for $1.5 billion in 2022 and is expected to reach $3.5 billion by 2028 growing at a CAGR of 15.2% during the forecast period. Tangential flow filtration (TFF) is an effective approach for biomolecule purification and separation. Tangential flow filtration, also known as cross-flow filtration, is useful in both the upstream processing of cell harvesting and the downstream processing approach utilised in bio-manufacturing. It concentrates and desalts sample solutions in amounts ranging from 10 mL to thousands of litres. It is obtained through massive fractionation of harvest cell suspensions, tiny biomolecules, fermentation broths, and cell lysates.
According to a US-based independent, academic, non-profit research center, Tufts Center for the Study of Drug Development's 2021 report, the global R&D spending by the largest publicly-traded biotech companies grew 13.7% annually, from $4.8 billion in 2001 to $55.0 billion in 2020
Typical tangential flow filtering processes include reverse osmosis and nanofiltration. In concentration and diafiltration techniques, tangential flow filtration is used. It increases a solution's concentration by removing liquids while maintaining the solute molecules. In diafiltration, tiny and giant particles separate, leaving the tinier particles behind without changing the total concentration at the end by washing out the rest of the salt with another buffer. This approach can also be used to reduce the concentration of a solution by washing away the remaining salts with water. Tangential flow filtration's increasing use is thus fuelling the growth of the Tangential Flow Filtration Market during the forecast period.
High capital expenditure is necessary to construct and establish new manufacturing facilities, which may be difficult or easy to option out by small-scale businesses. Furthermore, the presence of cutting-edge technologies such as centrifugation, direct flow filtration, and pre-coat filtration is expected to hamper the worldwide tangential flow filtration market's expansion. Furthermore, numerous pharmaceutical corporations are constantly outsourcing manufacturing in order to effectively utilise foreign technology, experience, and capacity. As a result, the prices of finished items may rise, stifling market expansion.
Tangential flow filtration (TFF) is an immediate and effective technique for biomolecule separation and purification. It is useful in many scientific domains, including immunology, protein chemistry, molecular biology (DNA/RNA/oligonucleotides), biochemistry, and microbiology. TFF has been used to concentrate and desalt proteins and peptides, recover and purify antibodies or recombinant proteins from cell culture medium, and fractionate dilute protein mixtures over the years. Recombinant proteins have received substantial momentum for therapeutic uses as the treatment pattern has shifted towards focused therapy. The biopharmaceutical industry's tendency of commercialising recombinant proteins is projected to drive the growth of the tangential flow filtration market.
The prevalence of rigorous government laws and regulations in the pharmaceutical business is expected to offer a challenge to the worldwide tangential flow filtration market during the forecast period. Furthermore, the market's presence of well-established and prominent competitors makes it difficult for new entrants to advertise their product offers and novel technology. Furthermore, important competitors in this market offer a wide selection of filtration products and have high levels of brand loyalty from customers, making it even more difficult for new entrants to establish a foothold in the industry.
The COVID-19 pandemic increased the global economic and social cost, prompting governments to increase vaccine development and manufacturing. Tangential flow filtration products are increasingly being used for COVID-19 research. To support downstream processes such as filtration and purification for vaccine development, various filtration techniques and materials are used. Moreover, some biopharmaceutical companies have incorporated several strategies to improve vaccine development and contain the pandemic. The COVID-19 epidemic has also created chances for filter manufacturers to expand their manufacturing facilities. As these filtering goods are utilised in the production of vaccines and other medicinal medications, the mass production of vaccines has favourably influenced the demand for tangential flow filtration products.
The membrane filters segment is estimated to have a lucrative growth, due to the use of filtering systems in numerous industries, particularly the pharmaceutical industry, is the primary driver of this segment's growth. The segment's expansion is being driven by the ease of access to various types of filters such as PCTE, PVDF, PTFE, and PES. Furthermore, the availability of diverse membrane filtration areas and pore sizes for relevant processes encourages segment expansion.
The microfiltration segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the increased use of microfiltration techniques during cell separation procedures. Microfiltration membranes, on the other hand, are used to handle a variety of challenges such as microbial removal, protein separation, and membrane treatment, which is driving the segment's expansion. Furthermore, these membranes are available in a variety of pore diameters ranging from 0.1 to 10 m, which aids in limiting fouling and fractionating suspended particles. These factors will contribute to the segment's growth during the predicted period.
Asia Pacific is projected to hold the largest market share during the forecast period owing to the growing demand for biologics and medicines, considerable investments from domestic and international firms, and the expansion of CMOs in emerging markets such as China, Japan, and South Korea are all driving to the industry's growth. Furthermore, the focus on treatment modernization, healthcare infrastructure development, and need for low-cost pharmaceuticals would drive the growth of the TFF market in APAC.
North America is projected to have the highest CAGR over the forecast period, owing to the increased bioprocessing activities to meet bio-therapeutic demand, increased frequency of chronic diseases and genetic abnormalities, expanding knowledge about treatment safety, and enhanced healthcare settings have all supported regional growth. Furthermore, the presence of a supportive government promotes development.
Some of the key players profiled in the Tangential Flow Filtration Market include: Andritz, Synder Filtration, INC., Merk KGAA, SPF Technologies, LLC, Parker Hannifin Corporation, Danaher Corporation, Sysbiotech Gmbh, Solaris Biotechnology SRL, Alfa Laval Corporate AB, Sartorius AG, Sterlitech Corporation, Koch Separation Solutions, Cole-Parmer Instrument Company, LLC, Repligen Corporation and Meissner Filtration Products, INC.
In December 2021, Donaldson Company (US) acquired Solaris (Italy), a company that designs and manufactures bioprocessing equipment, including tangential flow filtration systems for use in biotechnology, and other life sciences markets. This acquisition will expand the company's portfolio in the pharmaceutical industry.
In March 2020, Danaher acquired the biopharma business from General Electric Company. This division will be called Cytiva and will be a standalone company operating under the Danaher Life Sciences segment.